Home >> Life Sciences >> Medical Devices

Global Breast Cancer Liquid Biopsy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published: Sep-2018 | Format: PDF | Global Info Research | Number of pages: 123 | Code: MRS - 354976

Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.



Scope of the Report:

This report focuses on the Breast Cancer Liquid Biopsy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Breast Cancer Liquid Biopsy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.



Market Segment by Manufacturers, this report covers

    QIAGEN

    Roche Diagnostics

    Bio-Rad Laboratories

    Myriad Genetics

    Menarini Silicon Biosystems

    Genomic Health

    Thermo Fisher Scientific

    Illumina

    Biocept

    Trovagene

    Guardant Health

    RainDance Technologies

    MDx Health



Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia etc.)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

    Circulating Tumor Cells (CTCs)

    Cell-Free DNA (CfDNA)

    Extracellular Vesicles (EVs)

    Other Circulating Biomarkers



Market Segment by Applications, can be divided into

    Hospitals

    Diagnostic Centers

    Laboratories



There are 15 Chapters to deeply display the global Breast Cancer Liquid Biopsy market.

Chapter 1, to describe Breast Cancer Liquid Biopsy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Breast Cancer Liquid Biopsy, with sales, revenue, and price of Breast Cancer Liquid Biopsy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Breast Cancer Liquid Biopsy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Breast Cancer Liquid Biopsy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Breast Cancer Liquid Biopsy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents



1 Market Overview

    1.1 Breast Cancer Liquid Biopsy Introduction

    1.2 Market Analysis by Type

        1.2.1 Circulating Tumor Cells (CTCs)

        1.2.2 Cell-Free DNA (CfDNA)

        1.2.3 Extracellular Vesicles (EVs)

        1.2.4 Other Circulating Biomarkers

    1.3 Market Analysis by Applications

        1.3.1 Hospitals

        1.3.2 Diagnostic Centers

        1.3.3 Laboratories

    1.4 Market Analysis by Regions

        1.4.1 North America (United States, Canada and Mexico)

            1.4.1.1 United States Market States and Outlook (2013-2023)

            1.4.1.2 Canada Market States and Outlook (2013-2023)

            1.4.1.3 Mexico Market States and Outlook (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy)

            1.4.2.1 Germany Market States and Outlook (2013-2023)

            1.4.2.2 France Market States and Outlook (2013-2023)

            1.4.2.3 UK Market States and Outlook (2013-2023)

            1.4.2.4 Russia Market States and Outlook (2013-2023)

            1.4.2.5 Italy Market States and Outlook (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

            1.4.3.1 China Market States and Outlook (2013-2023)

            1.4.3.2 Japan Market States and Outlook (2013-2023)

            1.4.3.3 Korea Market States and Outlook (2013-2023)

            1.4.3.4 India Market States and Outlook (2013-2023)

            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

        1.4.4 South America, Middle East and Africa

            1.4.4.1 Brazil Market States and Outlook (2013-2023)

            1.4.4.2 Egypt Market States and Outlook (2013-2023)

            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

            1.4.4.4 South Africa Market States and Outlook (2013-2023)

            1.4.4.5 Nigeria Market States and Outlook (2013-2023)

    1.5 Market Dynamics

        1.5.1 Market Opportunities

        1.5.2 Market Risk

        1.5.3 Market Driving Force

2 Manufacturers Profiles

    2.1 QIAGEN

        2.1.1 Business Overview

        2.1.2 Breast Cancer Liquid Biopsy Type and Applications

            2.1.2.1 Product A

            2.1.2.2 Product B

        2.1.3 QIAGEN Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.2 Roche Diagnostics

        2.2.1 Business Overview

        2.2.2 Breast Cancer Liquid Biopsy Type and Applications

            2.2.2.1 Product A

            2.2.2.2 Product B

        2.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.3 Bio-Rad Laboratories

        2.3.1 Business Overview

        2.3.2 Breast Cancer Liquid Biopsy Type and Applications

            2.3.2.1 Product A

            2.3.2.2 Product B

        2.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.4 Myriad Genetics

        2.4.1 Business Overview

        2.4.2 Breast Cancer Liquid Biopsy Type and Applications

            2.4.2.1 Product A

            2.4.2.2 Product B

        2.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.5 Menarini Silicon Biosystems

        2.5.1 Business Overview

        2.5.2 Breast Cancer Liquid Biopsy Type and Applications

            2.5.2.1 Product A

            2.5.2.2 Product B

        2.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.6 Genomic Health

        2.6.1 Business Overview

        2.6.2 Breast Cancer Liquid Biopsy Type and Applications

            2.6.2.1 Product A

            2.6.2.2 Product B

        2.6.3 Genomic Health Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.7 Thermo Fisher Scientific

        2.7.1 Business Overview

        2.7.2 Breast Cancer Liquid Biopsy Type and Applications

            2.7.2.1 Product A

            2.7.2.2 Product B

        2.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.8 Illumina

        2.8.1 Business Overview

        2.8.2 Breast Cancer Liquid Biopsy Type and Applications

            2.8.2.1 Product A

            2.8.2.2 Product B

        2.8.3 Illumina Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.9 Biocept

        2.9.1 Business Overview

        2.9.2 Breast Cancer Liquid Biopsy Type and Applications

            2.9.2.1 Product A

            2.9.2.2 Product B

        2.9.3 Biocept Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.10 Trovagene

        2.10.1 Business Overview

        2.10.2 Breast Cancer Liquid Biopsy Type and Applications

            2.10.2.1 Product A

            2.10.2.2 Product B

        2.10.3 Trovagene Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.11 Guardant Health

        2.11.1 Business Overview

        2.11.2 Breast Cancer Liquid Biopsy Type and Applications

            2.11.2.1 Product A

            2.11.2.2 Product B

        2.11.3 Guardant Health Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.12 RainDance Technologies

        2.12.1 Business Overview

        2.12.2 Breast Cancer Liquid Biopsy Type and Applications

            2.12.2.1 Product A

            2.12.2.2 Product B

        2.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.13 MDx Health

        2.13.1 Business Overview

        2.13.2 Breast Cancer Liquid Biopsy Type and Applications

            2.13.2.1 Product A

            2.13.2.2 Product B

        2.13.3 MDx Health Breast Cancer Liquid Biopsy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Breast Cancer Liquid Biopsy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    3.1 Global Breast Cancer Liquid Biopsy Sales and Market Share by Manufacturer (2016-2017)

    3.2 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Manufacturer (2016-2017)

    3.3 Market Concentration Rate

        3.3.1 Top 3 Breast Cancer Liquid Biopsy Manufacturer Market Share in 2017

        3.3.2 Top 6 Breast Cancer Liquid Biopsy Manufacturer Market Share in 2017

    3.4 Market Competition Trend

4 Global Breast Cancer Liquid Biopsy Market Analysis by Regions

    4.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Regions

        4.1.1 Global Breast Cancer Liquid Biopsy Sales and Market Share by Regions (2013-2018)

        4.1.2 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Regions (2013-2018)

    4.2 North America Breast Cancer Liquid Biopsy  Sales and Growth Rate (2013-2018)

    4.3 Europe Breast Cancer Liquid Biopsy  Sales and Growth Rate (2013-2018)

    4.4 Asia-Pacific Breast Cancer Liquid Biopsy  Sales and Growth Rate (2013-2018)

    4.5 South America Breast Cancer Liquid Biopsy  Sales and Growth Rate (2013-2018)

    4.6 Middle East and Africa Breast Cancer Liquid Biopsy  Sales and Growth Rate (2013-2018)

5 North America Breast Cancer Liquid Biopsy by Countries

    5.1 North America Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

        5.1.1 North America Breast Cancer Liquid Biopsy Sales and Market Share by Countries (2013-2018)

        5.1.2 North America Breast Cancer Liquid Biopsy Revenue and Market Share by Countries (2013-2018)

    5.2 United States Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    5.3 Canada Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    5.4 Mexico Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

6 Europe Breast Cancer Liquid Biopsy by Countries

    6.1 Europe Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

        6.1.1 Europe Breast Cancer Liquid Biopsy Sales and Market Share by Countries (2013-2018)

        6.1.2 Europe Breast Cancer Liquid Biopsy Revenue and Market Share by Countries (2013-2018)

    6.2 Germany Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    6.3 UK Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    6.4 France Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    6.5 Russia Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    6.6 Italy Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

7 Asia-Pacific Breast Cancer Liquid Biopsy by Countries

    7.1 Asia-Pacific Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

        7.1.1 Asia-Pacific Breast Cancer Liquid Biopsy Sales and Market Share by Countries (2013-2018)

        7.1.2 Asia-Pacific Breast Cancer Liquid Biopsy Revenue and Market Share by Countries (2013-2018)

    7.2 China Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    7.3 Japan Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    7.4 Korea Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    7.5 India Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    7.6 Southeast Asia Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

8 South America Breast Cancer Liquid Biopsy by Countries

    8.1 South America Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

        8.1.1 South America Breast Cancer Liquid Biopsy Sales and Market Share by Countries (2013-2018)

        8.1.2 South America Breast Cancer Liquid Biopsy Revenue and Market Share by Countries (2013-2018)

    8.2 Brazil Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    8.3 Argentina Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    8.4 Colombia Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

9 Middle East and Africa Breast Cancer Liquid Biopsy by Countries

    9.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Countries

        9.1.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales and Market Share by Countries (2013-2018)

        9.1.2 Middle East and Africa Breast Cancer Liquid Biopsy Revenue and Market Share by Countries (2013-2018)

    9.2 Saudi Arabia Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    9.3 UAE Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    9.4 Egypt Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    9.5 Nigeria Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

    9.6 South Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (2013-2018)

10 Global Breast Cancer Liquid Biopsy Market Segment by Type

    10.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Market Share by Type (2013-2018)

        10.1.1 Global Breast Cancer Liquid Biopsy Sales and Market Share by Type (2013-2018)

        10.1.2 Global Breast Cancer Liquid Biopsy Revenue and Market Share by Type (2013-2018)

    10.2 Circulating Tumor Cells (CTCs) Sales Growth and Price

        10.2.1 Global Circulating Tumor Cells (CTCs) Sales Growth (2013-2018)

        10.2.2 Global Circulating Tumor Cells (CTCs) Price (2013-2018)

    10.3 Cell-Free DNA (CfDNA) Sales Growth and Price

        10.3.1 Global Cell-Free DNA (CfDNA) Sales Growth (2013-2018)

        10.3.2 Global Cell-Free DNA (CfDNA) Price (2013-2018)

    10.4 Extracellular Vesicles (EVs) Sales Growth and Price

        10.4.1 Global Extracellular Vesicles (EVs) Sales Growth (2013-2018)

        10.4.2 Global Extracellular Vesicles (EVs) Price (2013-2018)

    10.5 Other Circulating Biomarkers Sales Growth and Price

        10.5.1 Global Other Circulating Biomarkers Sales Growth (2013-2018)

        10.5.2 Global Other Circulating Biomarkers Price (2013-2018)

11 Global Breast Cancer Liquid Biopsy Market Segment by Application

    11.1 Global Breast Cancer Liquid Biopsy Sales Market Share by Application (2013-2018)

    11.2 Hospitals Sales Growth (2013-2018)

    11.3 Diagnostic Centers Sales Growth (2013-2018)

    11.4 Laboratories Sales Growth (2013-2018)

12 Breast Cancer Liquid Biopsy Market Forecast (2018-2023)

    12.1 Global Breast Cancer Liquid Biopsy Sales, Revenue and Growth Rate (2018-2023)

    12.2 Breast Cancer Liquid Biopsy Market Forecast by Regions (2018-2023)

        12.2.1 North America Breast Cancer Liquid Biopsy Market Forecast (2018-2023)

        12.2.2 Europe Breast Cancer Liquid Biopsy Market Forecast (2018-2023)

        12.2.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Forecast (2018-2023)

        12.2.4 South America Breast Cancer Liquid Biopsy Market Forecast (2018-2023)

        12.2.5 Middle East and Africa Breast Cancer Liquid Biopsy Market Forecast (2018-2023)

    12.3 Breast Cancer Liquid Biopsy Market Forecast by Type (2018-2023)

        12.3.1 Global Breast Cancer Liquid Biopsy Sales Forecast by Type (2018-2023)

        12.3.2 Global Breast Cancer Liquid Biopsy Market Share Forecast by Type (2018-2023)

    12.4 Breast Cancer Liquid Biopsy Market Forecast by Application (2018-2023)

        12.4.1 Global Breast Cancer Liquid Biopsy Sales Forecast by Application (2018-2023)

        12.4.2 Global Breast Cancer Liquid Biopsy Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

    13.1 Sales Channel

        13.1.1 Direct Marketing

        13.1.2 Indirect Marketing

        13.1.3 Marketing Channel Future Trend

    13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

    15.1 Methodology

    15.2 Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)3480 View Pricing